Carregant...
GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies
After the first case of Coronavirus disease 2019 (COVID-19) was reported in Wuhan, COVID-19 has rapidly spread to almost all parts of world. Angiotensin converting enzyme 2 (ACE2) receptor can bind to spike protein of SARS-CoV-2. Then, the spike protein of SARS-CoV-2 can be cleaved and activated by...
Guardat en:
| Publicat a: | Biomed Pharmacother |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Author(s). Published by Elsevier Masson SAS.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547400/ https://ncbi.nlm.nih.gov/pubmed/33049583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2020.110816 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|